• DIAH LIA AULIFA Department of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran
  • ARIF BUDIMAN Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran



mesoporous silica, pore size, drug loading, DSC curve.


Objective: The loading of drugs into mesoporous silica (MS) is an effective strategy to improve the solubility of poorly water-soluble drugs. Previous reports have stated that the surface area and pore volume of MS can affect drug loading and its crystallization in MS. Therefore, this study aims to elucidate the effect of MS pore size on the maximum drug loading and its dissolution profile.

Methods: The ritonavir (RTV) and itraconazole (ITZ) were encapsulated-MS using the solvent evaporation method. The RTV and ITZ loaded-MS were characterized using the differential scanning calorimetry (DSC) and PXRD measurement.

Results: The amorphization of RTV loaded-MPS and ITZ loaded-MPS were confirmed as a halo pattern in the powder X-ray diffraction pattern. The melting peak and the glass transition of RTV and ITZ were not discovered in MS with the pore size of 80 Å (weight ratio of 3:7), while in the RTV and ITZ loaded-MS with the pore size of 45 Å, the melting peak and the glass transition were observed. This indicated that the loading amount of RTV and ITZ with larger pore sizes is higher than the lower sizes.

Conclusion: This study demonstrated that the pore size of MS has a significant effect on the loading amount of drugs in MS.


Download data is not yet available.


Raghuram M, Alam MS, Prasad M, Khanduri CH. Pharmaceutical cocrystal of prulifloxacin with nicotinamide. Int J Pharm Pharm Sci 2014;6(10):180-4.

Vraníková B, Niederquell A, Šklubalová Z, Kuentz M. Relevance of the theoretical critical pore radius in mesoporous silica for fast crystallizing drugs. Int J Pharm 2020 Dec;591:120019.

Reddy adena SK, Matte KV, Kosuru R. Formulation, optimization, and in vitro characterization of dasatinib loaded polymeric nanocarriers to extend the release of the model drug. Int J App Pharm 2021 Sep 7;13(5):318-30.

Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 2011 Nov 25;420(1):1-0.

Dening TJ, Taylor LS. Supersaturation potential of ordered mesoporous silica delivery systems. Part 1: Dissolution performance and drug membrane transport rates. Mol Pharm 2018 Jul 9;15(8):3489-501.

Skorupska E, Jeziorna A, Potrzebowski MJ. Thermal solvent-free method of loading of pharmaceutical cocrystals into the pores of silica particles: A case of naproxen/picolinamide cocrystal. J Phys Chem C 2016 June 23;120(24):13169-80.

Skorupska E, Kaźmierski S, Potrzebowski MJ. Solid state NMR characterization of ibuprofen: nicotinamide cocrystals and new idea for controlling release of drugs embedded into mesoporous silica particles. Mol Pharm 2017 May 1;14(5):1800-10.

Okada H, Ueda K, Yasuda Y, Higashi K, Inoue M, Ito M, Noguchi S, Kawakami K, Moribe K. Correlation between drug dissolution and resistance to water-induced phase separation in solid dispersion formulations revealed by solid-state NMR spectroscopy. Int J Pharm 2020 Mar 15;577:119086.

Murdande SB, Pikal MJ, Shanker RM, Bogner RH. Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals. Pharm Res 2010 Dec;27(12):2704-14.

Babu NJ, Nangia A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des 2011 Jul 6;11(7):2662-79.

Azad M, Moreno J, Davé R. Stable and fast-dissolving amorphous drug composites preparation via impregnation of Neusilin® UFL2. J Pharm Sci 2018 Jan 1;107(1):170-82.

Yamamoto K, Kojima T, Karashima M, Ikeda Y. Physicochemical evaluation and developability assessment of co-amorphouses of low soluble drugs and comparison to the co-crystals. Chem Pharm Bull 2016:c16-00604.

Czarnobaj K, Prokopowicz M, Greber K. Use of materials based on polymeric silica as bone-targeted drug delivery systems for metronidazole. Int J Mol Sci 2019 Mar 15;20(6):1311.

Qian S, Heng W, Wei Y, Zhang J, Gao Y. Coamorphous lurasidone hydrochloride–saccharin with charge-assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with pH-independent solubility behavior. Cryst Growth 2015 Dec 3;15(6):2920-8.

McCarthy CA, Zemlyanov DY, Crean AM, Taylor LS. Comparison of drug release and adsorption under supersaturating conditions for ordered mesoporous silica with indomethacin or indomethacin methyl ester. Mol Pharm 2020 Jul 7;17(8):3062-74.

Andersson J, Rosenholm J, Areva S, Lindén M. Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro-and mesoporous silica matrices. Chem Mater 2004 Oct 19;16(21):4160-7.

Antonino RS, Ruggiero M, Song Z, Nascimento TL, Lima EM, Bohr A, Knopp MM, Löbmann K. Impact of drug loading in mesoporous silica-amorphous formulations on the physical stability of drugs with high recrystallization tendency. Int J Pharm X 2019 Dec 1;1:100026.

Bavnhøj CG, Knopp MM, Madsen CM, Löbmann K. The role interplay between mesoporous silica pore volume and surface area and their effect on drug loading capacity. Int J Pharm X 2019 Dec 1;1:100008.

Shen SC, Ng WK, Chia L, Hu J, Tan RB. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int J Pharm 2011 May 30;410(1-2):188-95.

Thomas MJ, Slipper I, Walunj A, Jain A, Favretto ME, Kallinteri P, Douroumis D. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. Int J Pharm 2010 Mar 15;387(1-2):272-7.

Budiman A, Aulifa DL. Characterization of Drugs with Good Glass Formers in Loaded-Mesoporous Silica and Its Theoretical Value Relevance with Mesopores Surface and Pore-Filling Capacity. Pharmaceuticals 2022 Jan 13;15(1):93.

Budiman A, Higashi K, Ueda K, Moribe K. Effect of drug-coformer interactions on drug dissolution from a coamorphous in mesoporous silica. Int J Pharm 2021 May 1;600:120492.

Liu N, Higashi K, Kikuchi J, Ando S, Kameta N, Ding W, Masuda M, Shimizu T, Ueda K, Yamamoto K, Moribe K. Molecular-level understanding of the encapsulation and dissolution of poorly water-soluble ibuprofen by functionalized organic nanotubes using solid-state NMR spectroscopy. J Phys Chem B 2016 May 19;120(19):4496-507.

Tanabe S, Higashi K, Umino M, Limwikrant W, Yamamoto K, Moribe K. Yellow coloration phenomena of incorporated indomethacin into folded sheet mesoporous materials. Int J Pharm 2012 June 15;429(1-2):38-45.

Kozyra A, Mugheirbi NA, Paluch KJ, Garbacz G, Tajber L. Phase diagrams of polymer-dispersed liquid crystal systems of itraconazole/component immiscibility induced by molecular anisotropy. Mol Pharm 2018 Sep 25;15(11):5192-206.



How to Cite




Original Article(s)

Most read articles by the same author(s)

1 2 > >>